|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Villanueva A, Minguez B, Forner A, Reig M
and Llovet JM: Hepatocellular carcinoma: Novel molecular approaches
for diagnosis, prognosis, and therapy. Annu Rev Med. 61:317–328.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yau T, Chan P, Epstein R and Poon RT:
Evolution of systemic therapy of advanced hepatocellular carcinoma.
World J Gastroenterol. 14:6437–6441. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY,
Bae HI, Yun YK and Hwang YJ: Prognostic factors after early
recurrence in patients who underwent curative resection for
hepatocellular carcinoma. J Surg Oncol. 103:148–151. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX and
Xiang BD: Cancer stem cell markers correlate with early recurrence
and survival in hepatocellular carcinoma. World J Gastroenterol.
20:2098–2106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma S, Lee TK, Zheng BJ, Chan KW and Guan
XY: CD133+ HCC cancer stem cells confer chemoresistance by
preferential expression of the Akt/PKB survival pathway. Oncogene.
27:1749–1758. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sell S and Leffert HL: Liver cancer stem
cells. J Clin Oncol. 26:2800–2805. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li J, Yu Y, Wang J, Yan Z, Liu H, Wang Y,
Ding M, Cui L, Wu M, Jiang X and Qian Q: Establishment of a novel
system for the culture and expansion of hepatic stem-like cancer
cells. Cancer Lett. 360:177–186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai
P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of CD90+ cancer
stem cells in human liver cancer. Cancer Cell. 13:153–166. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamashita T, Forgues M, Wang W, Kim JW, Ye
Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, et al: EpCAM and
alpha-fetoprotein expression defines novel prognostic subtypes of
hepatocellular carcinoma. Cancer Res. 68:1451–1461. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szeto CY, Lin CH, Choi SC, Yip TT, Ngan
RK, Tsao GS and Li Lung M: Integrated mRNA and microRNA
transcriptome sequencing characterizes sequence variants and
mRNA-microRNA regulatory network in nasopharyngeal carcinoma model
systems. FEBS Open Biol. 4:128–140. 2014. View Article : Google Scholar
|
|
13
|
Lin T, Liu Q and Chen J: Identification of
differentially expressed genes in Monochamus alternatus digested
with azadirachtin. Sci Rep. 6:334842016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li R, Li Y, Kristiansen K and Wang J:
SOAP: Short oligonucleotide alignment program. Bioinformatics.
24:713–714. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mortazavi A, Williams BA, McCue K,
Schaeffer L and Wold B: Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods. 5:621–628. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Hoon MJ, Imoto S, Nolan J and Miyano S:
Open source clustering software. Bioinformatics. 20:1453–1454.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye J, Zhang Y, Cui H, Liu J, Wu Y, Cheng
Y, Xu H, Huang X, Li S, Zhou A, et al: WEGO 2.0: A web tool for
analyzing and plotting GO annotations, 2018 update. Nucleic Acids
Res. 46:W71–W75. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T
and Yamanishi Y: KEGG for linking genomes to life and the
environment. Nucleic Acids Res. 36((Database Issue)): D480–D484.
2008.PubMed/NCBI
|
|
19
|
Maragkakis M, Vergoulis T, Alexiou P,
Reczko M, Plomaritou K, Gousis M, Kourtis K, Koziris N, Dalamagas T
and Hatzigeorgiou AG: DIANA-microT Web server upgrade supports fly
and worm miRNA target prediction and bibliographic miRNA to disease
association. Nucleic Acids Res. 39((Web Server Issue)): W145–W148.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X: miRDB: A microRNA target
prediction and functional annotation database with a wiki
interface. RNA. 14:1012–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rehmsmeier M, Steffen P, Hochsmann M and
Giegerich R: Fast and effective prediction of microRNA/target
duplexes. RNA. 10:1507–1517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kertesz M, Iovino N, Unnerstall U, Gaul U
and Segal E: The role of site accessibility in microRNA target
recognition. Nat Genet. 39:1278–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miranda KC, Huynh T, Tay Y, Ang YS, Tam
WL, Thomson AM, Lim B and Rigoutsos I: A pattern-based method for
the identification of MicroRNA binding sites and their
corresponding heteroduplexes. Cell. 126:1203–1217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsai TH, Song E, Zhu R, Di Poto C, Wang M,
Luo Y, Varghese RS, Tadesse MG, Ziada DH, Desai CS, et al:
LC-MS/MS-based serum proteomics for identification of candidate
biomarkers for hepatocellular carcinoma. Proteomics. 15:2369–2381.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang L, Guo Y, Li B, Qu J, Zang C, Li F,
Wang Y, Pang H, Li S and Liu Q: Identification of biomarkers for
hepatocellular carcinoma using network-based bioinformatics
methods. Eur J Med Res. 18:352013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lv J, Zhu B, Zhang L, Xie Q and Zhuo W:
Detection and screening of small molecule agents for overcoming
Sorafenib resistance of hepatocellular carcinoma: A bioinformatics
study. Int J Clin Exp Med. 8:2317–2325. 2015.PubMed/NCBI
|
|
31
|
Kesselring R, Thiel A, Pries R,
Fichtner-Feigl S, Brunner S, Seidel P, Bruchhage KL and Wollenberg
B: The complement receptors CD46, CD55 and CD59 are regulated by
the tumour microenvironment of head and neck cancer to facilitate
escape of complement attack. Eur J Cancer. 50:2152–2161. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Riihilä P, Nissinen L, Farshchian M,
Kivisaari A, Ala-Aho R, Kallajoki M, Grénman R, Meri S, Peltonen S,
Peltonen J and Kähäri VM: Complement factor I promotes progression
of cutaneous squamous cell carcinoma. J Invest Dermatol.
135:579–588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Okroj M, Holmquist E, Nilsson E,
Anagnostaki L, Jirström K and Blom AM: Local expression of
complement factor I in breast cancer cells correlates with poor
survival and recurrence. Cancer Immunol Immunother. 64:467–478.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu W, Liu B, Xin L, Zhang Y, Chen X, Zhu
Z and Lin Y: Down-regulated expression of complement factor I: A
potential suppressive protein for gastric cancer identified by
serum proteome analysis. Clin Chim Acta. 377:119–126. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He X, Wang Y, Zhang W, Li H, Luo R, Zhou
Y, Liao CL, Huang H, Lv X, Xie Z and He M: Screening differential
expression of serum proteins in AFP-negative HBV-related
hepatocellular carcinoma using iTRAQ-MALDI-MS/MS. Neoplasma.
61:17–26. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jing Y, Jia D, Wong CM, Oi-Lin Ng I, Zhang
Z, Liu L, Wang Q, Zhao F, Li J, Yao M, et al: SERPINA5 inhibits
tumor cell migration by modulating the fibronectin-integrin β1
signaling pathway in hepatocellular carcinoma. Mol Oncol.
8:366–377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shalom-Feuerstein R, Serror L, De La
Forest Divonne S, Petit I, Aberdam E, Camargo L, Damour O,
Vigouroux C, Solomon A, Gaggioli C, et al: Pluripotent stem cell
model reveals essential roles for miR-450b-5p and miR-184 in
embryonic corneal lineage specification. Stem Cells. 30:898–909.
2012. View Article : Google Scholar : PubMed/NCBI
|
